{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:30:28Z","timestamp":1776382228072,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The European pediatric soft tissue Sarcoma Study Group (E<jats:italic>p<\/jats:italic>SSG) RMS 2005 study recommends a lymph node biopsy for extremity rhabdomyosarcoma (RMS). The aim of our study was to analyze the results of the lymph node sampling strategies used, such as sentinel node biopsy (SNB) and nodal sampling (NS), and compare the outcome of patients undergoing different nodal staging techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All non-metastatic (M0) patients registered in the E<jats:italic>p<\/jats:italic>SSG RMS 2005 study with an RMS of the extremity, presenting between 2005 and 2016, were included for analysis of the lymph node sampling techniques used. The secondary objective was to compare the results and outcome for the different sampling procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 198 patients, 144 had clinically\/radiologically negative nodes (cN0), and 72\/144 underwent a biopsy (26 SNB\/46 NS). Final nodal status was upstaged to pN1 in 11\/72 (15.3%) patients\u20146 after SNB and 5 after NS. In 54 radiologically malignant\/suspicious-appearing nodes, 34 NS biopsies were performed, resulting in downstaging to N0 in 9\/34 (26.5%) patients. 5-years overall survival (OS) of N0 patients versus N1 patients was 82.5% (95% confidence interval CI 74.7\u201388.0) versus 46.5% (95% CI 32.2\u201359.7). 5-years OS in N0 patients was not significantly different in biopsied and non-biopsied patients (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.88). However, in N1 patients, survival was significantly better in biopsied compared with non-biopsied patients (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Lymph node staging plays a crucial role in determining appropriate treatment strategies. Pathology of sampled lymph nodes can upstage or downstage the lymph node status, guiding treatment decisions based on the stage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17908-3","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:24:09Z","timestamp":1753367049000},"page":"7751-7761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgical Lymph Node Staging in Extremity Rhabdomyosarcoma: The EpSSG RMS 2005 Trial Experience"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-0208","authenticated-orcid":false,"given":"Sheila","family":"Terwisscha van Scheltinga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes H. M.","family":"Merks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross J.","family":"Craigie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"De Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Dall\u2019Igna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"D\u00e1vila Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriel","family":"Jenney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia C.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Minard-Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Cesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Jehanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Hiemcke-Jiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Coppadoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida F. W.","family":"van der Steeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max M.","family":"van Noesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H. W. A.","family":"Wijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"12","key":"17908_CR1","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/pbc.25684","volume":"62","author":"O Oberlin","year":"2015","unstructured":"Oberlin O, Rey A, Brown KLB, Bisogno G, Koscielniak E, Stevens MCG, et al. Prognostic factors for outcome in localized extremity rhabdomyosarcoma. Pooled analysis from four international cooperative groups. Pediatr Blood Cancer. 2015;62(12):2125\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"17908_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00066-021-01780-7","volume":"197","author":"J Welmant","year":"2021","unstructured":"Welmant J, Helfre S, Carton M, Bolle S, Minard-Colin V, Corradini N, et al. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered. Strahlenther Onkol. 2021;197(8):690\u20139.","journal-title":"Strahlenther Onkol"},{"issue":"20","key":"17908_CR3","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.1002\/cam4.3365","volume":"9","author":"SSEJ van Terwisscha","year":"2020","unstructured":"van Terwisscha SSEJ, Wijnen MHWA, Martelli H, Rogers T, Mandeville H, Gaze MN, et al. Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study. Cancer Med. 2020;9(20):7580\u20139.","journal-title":"Cancer Med"},{"issue":"3","key":"17908_CR4","doi-asserted-by":"publisher","first-page":"e28832","DOI":"10.1002\/pbc.28832","volume":"68","author":"S Gallego","year":"2021","unstructured":"Gallego S, Chi YY, De Salvo GL, Li M, Merks JHM, Rodeberg DA, et al. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Pediatr Blood Cancer. 2021;68(3):e28832.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"17908_CR5","doi-asserted-by":"publisher","first-page":"e28608","DOI":"10.1002\/pbc.28608","volume":"70","author":"CD Morris","year":"2020","unstructured":"Morris CD, Tunn PU, Rodeberg DA, Terwisscha van Scheltinga S, Binitie O, Godzinski J, et al. Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the children\u2019s oncology group, the European pediatric soft-tissue sarcoma study group, and the cooperative weichteilsarkom studiengruppe. Pediatr Blood Cancer. 2020;70(3):e28608.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"17908_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0022-3468(00)90031-9","volume":"35","author":"HL Neville","year":"2000","unstructured":"Neville HL, Andrassy RJ, Lobe TE, Bagwell CE, Anderson JR, Womer RB, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991\u20131997). J Pediatr Surg. 2000;35(2):317\u201321.","journal-title":"J Pediatr Surg"},{"issue":"7","key":"17908_CR7","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.ejso.2022.03.001","volume":"48","author":"CEJ Terwisscha van Scheltinga","year":"2022","unstructured":"Terwisscha van Scheltinga CEJ, Wijnen MHWA, Martelli H, Guerin F, Rogers T, Craigie RJ, et al. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: analysis of the EpSSG RMS 2005 study. Eur J Surg Oncol. 2022;48(7):1536\u201342.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"17908_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jpedsurg.2016.08.024","volume":"52","author":"I Lobeck","year":"2017","unstructured":"Lobeck I, Dupree P, Karns R, Rodeberg D, von Allmen D, Dasgupta R. Quality assessment of lymph node sampling in rhabdomyosarcoma: a surveillance, epidemiology, and end results (SEER) program study. J Pediatr Surg. 2017;52(4):614\u20137.","journal-title":"J Pediatr Surg"},{"key":"17908_CR9","unstructured":"EpSSG (European Soft Tissue Sarcoma Study Group). protocol for non-metastatic rhabdomyosarcoma in children. 2006. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00339118?term=NCT00339118&draw=2&rank=1"},{"issue":"8","key":"17908_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(18)30337-1","volume":"19","author":"G Bisogno","year":"2018","unstructured":"Bisogno G, Jenney M, Bergeron C, Gallego Melc\u00f3n S, Ferrari A, Oberlin O, et al. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Oncol. 2018;19(8):1061\u201371.","journal-title":"Lancet Oncol."},{"issue":"13","key":"17908_CR11","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1200\/JCO.22.02093","volume":"41","author":"G Bisogno","year":"2023","unstructured":"Bisogno G, Minard-Colin V, Zanetti I, Ferrari A, Gallego S, D\u00e1vila Fajardo R, et al. Nonmetastatic rhabdomyosarcoma in children and adolescents: overall results of the European pediatric soft tissue sarcoma study group RMS2005 study. J Clin Oncol. 2023;41(13):2342\u20139.","journal-title":"J Clin Oncol"},{"key":"17908_CR12","doi-asserted-by":"publisher","first-page":"169S","DOI":"10.1245\/ASO.2004.12.911","volume":"11","author":"OE Nieweg","year":"2004","unstructured":"Nieweg OE. What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol. 2004;11:169S-173S.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"17908_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4048\/jbc.2017.20.3.217","volume":"20","author":"S Zahoor","year":"2017","unstructured":"Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217.","journal-title":"J Breast Cancer"},{"issue":"30","key":"17908_CR14","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703\u201320.","journal-title":"J Clin Oncol"},{"issue":"3","key":"17908_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","volume":"242","author":"DL Morton","year":"2005","unstructured":"Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302\u201313.","journal-title":"Ann Surg"},{"issue":"9","key":"17908_CR16","doi-asserted-by":"publisher","first-page":"e28479","DOI":"10.1002\/pbc.28479","volume":"67","author":"TN Rogers","year":"2020","unstructured":"Rogers TN, De Corti F, Burrieza GG, Gu\u00e9rin F, van Terwisscha SS, Smeulders N, et al. Paratesticular rhabdomyosarcoma\u2014impact of locoregional approach on patient outcome: a report from the European paediatric Soft tissue sarcoma Study Group (EpSSG). Pediatr Blood Cancer. 2020;67(9):e28479.","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"17908_CR17","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1200\/JCO.2004.04.083","volume":"22","author":"M Carli","year":"2004","unstructured":"Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol. 2004;22(23):4787\u201394.","journal-title":"J Clin Oncol"},{"issue":"3","key":"17908_CR18","doi-asserted-by":"publisher","first-page":"e27532","DOI":"10.1002\/pbc.27532","volume":"66","author":"B Turpin","year":"2019","unstructured":"Turpin B, Pressey JG, Nagarajan R, Weiss BD, Trout AT, Gelfand MJ, et al. Sentinel lymph node biopsy in head and neck rhabdomyosarcoma. Pediatr Blood Cancer. 2019;66(3):e27532.","journal-title":"Pediatr Blood Cancer."},{"issue":"12","key":"17908_CR19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.jpedsurg.2020.03.022","volume":"55","author":"SA Mansfield","year":"2020","unstructured":"Mansfield SA, Murphy AJ, Talbot L, Prajapati H, Maller V, Pappo A, et al. Alternative approaches to retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma. J Pediatr Surg. 2020;55(12):2677\u201381.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"17908_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.31557\/APJCP.2020.21.5.1187","volume":"21","author":"S Thongvitokomarn","year":"2020","unstructured":"Thongvitokomarn S, Polchai N. Indocyanine green fluorescence versus blue dye or radioisotope regarding detection rate of sentinel lymph node biopsy and nodes removed in breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prevent. 2020;21(5):1187.","journal-title":"Asian Pac J Cancer Prevent"},{"issue":"11","key":"17908_CR21","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.ejso.2020.07.012","volume":"46","author":"B Jeremiasse","year":"2020","unstructured":"Jeremiasse B, van den Bosch CH, Wijnen MWHA, van Terwisscha SCEJ, Fiocco MF, van der Steeg AFW. Systematic review and meta-analysis concerning near-infrared imaging with fluorescent agents to identify the sentinel lymph node in oncology patients. Eur J Surg Oncol. 2020;46(11):2011\u201322.","journal-title":"Eur J Surg Oncol"},{"key":"17908_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1542\/peds.147.3MA9.926","volume":"147","author":"R Dasgupta","year":"2021","unstructured":"Dasgupta R, Westmoreland T, Malek MM, Austin MT, Poulos N, Aldrink JH. 99mTc-Tilmanocept for pediatric sentinel lymph node biopsy (SLNB)? Results of a prospective, open-label multicenter trial evaluating SLNB in pediatric patients with solid tumors. Pediatrics. 2021;147:926.","journal-title":"Pediatrics"},{"issue":"3","key":"17908_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00259-020-04984-8","volume":"48","author":"IJ den Toom","year":"2021","unstructured":"den Toom IJ, Mahieu R, van Rooij R, van Es RJJ, Hobbelink MGG, Krijger GC, et al. Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid. Eur J Nucl Med Mol Imaging. 2021;48(3):851\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17908-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:06:08Z","timestamp":1758549968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17908-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17908"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17908-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sheila Terwisscha van Scheltinga, Johannes H.M. Merks, Florent Guerin, Timothy Rogers, Ross J. Craigie, Gabriela Guill\u00e9n, Federica De Corti, Patrizia Dall\u2019Igna, Raquel D\u00e1vila Fajardo, Gianni Bisogno, Andrea Ferrari, Daniel Orbach, Meriel Jenney, Julia C. Chisholm, V\u00e9ronique Minard-Colin, Maya Cesen MD, Nina Jehanno, Laura S. Hiemcke-Jiwa, Ilaria Zanetti, Beatrice Coppadoro, Alida F.W. van der Steeg, Max M. van Noesel, Marc H.W.A. Wijnen have no conflicts of interest to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}